BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29061651)

  • 1. TRPC5 Does Not Cause or Aggravate Glomerular Disease.
    Wang X; Dande RR; Yu H; Samelko B; Miller RE; Altintas MM; Reiser J
    J Am Soc Nephrol; 2018 Feb; 29(2):409-415. PubMed ID: 29061651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the TRPC5 ion channel protects the kidney filter.
    Schaldecker T; Kim S; Tarabanis C; Tian D; Hakroush S; Castonguay P; Ahn W; Wallentin H; Heid H; Hopkins CR; Lindsley CW; Riccio A; Buvall L; Weins A; Greka A
    J Clin Invest; 2013 Dec; 123(12):5298-309. PubMed ID: 24231357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.
    Carson C; Raman P; Tullai J; Xu L; Henault M; Thomas E; Yeola S; Lao J; McPate M; Verkuyl JM; Marsh G; Sarber J; Amaral A; Bailey S; Lubicka D; Pham H; Miranda N; Ding J; Tang HM; Ju H; Tranter P; Ji N; Krastel P; Jain RK; Schumacher AM; Loureiro JJ; George E; Berellini G; Ross NT; Bushell SM; Erdemli G; Solomon JM
    PLoS One; 2015; 10(6):e0127498. PubMed ID: 26098886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5.
    Polat OK; Isaeva E; Sudhini YR; Knott B; Zhu K; Noben M; Suresh Kumar V; Endlich N; Mangos S; Reddy TV; Samelko B; Wei C; Altintas MM; Dryer SE; Sever S; Staruschenko A; Reiser J
    Kidney Int; 2023 Jun; 103(6):1056-1062. PubMed ID: 36750145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
    Zhou Y; Castonguay P; Sidhom EH; Clark AR; Dvela-Levitt M; Kim S; Sieber J; Wieder N; Jung JY; Andreeva S; Reichardt J; Dubois F; Hoffmann SC; Basgen JM; Montesinos MS; Weins A; Johnson AC; Lander ES; Garrett MR; Hopkins CR; Greka A
    Science; 2017 Dec; 358(6368):1332-1336. PubMed ID: 29217578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.
    Akbulut Y; Gaunt HJ; Muraki K; Ludlow MJ; Amer MS; Bruns A; Vasudev NS; Radtke L; Willot M; Hahn S; Seitz T; Ziegler S; Christmann M; Beech DJ; Waldmann H
    Angew Chem Int Ed Engl; 2015 Mar; 54(12):3787-91. PubMed ID: 25707820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient Receptor Potential Canonical Channels 4 and 5 Mediate
    Pereira DMS; Mendes SJF; Alawi K; Thakore P; Aubdool A; Sousa NCF; da Silva JFR; Castro JA; P Pereira IC; Silva LCN; Grisotto MAG; Monteiro-Neto V; Costa SKP; da Costa R; Calixto JB; Brain SD; Fernandes ES
    Oxid Med Cell Longev; 2018; 2018():4904696. PubMed ID: 29983857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.
    Alawi KM; Russell FA; Aubdool AA; Srivastava S; Riffo-Vasquez Y; Baldissera L; Thakore P; Saleque N; Fernandes ES; Walsh DA; Brain SD
    Ann Rheum Dis; 2017 Jan; 76(1):252-260. PubMed ID: 27165180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Characterization of Transient Receptor Potential (TRP) Channel C5 in Female Murine Gonadotropes.
    Beck A; Götz V; Qiao S; Weissgerber P; Flockerzi V; Freichel M; Boehm U
    Endocrinology; 2017 Apr; 158(4):887-902. PubMed ID: 28324107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite regulatory effects of TRPC1 and TRPC5 on neurite outgrowth in PC12 cells.
    Heo DK; Chung WY; Park HW; Yuan JP; Lee MG; Kim JY
    Cell Signal; 2012 Apr; 24(4):899-906. PubMed ID: 22201561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRPC5 channel regulates angiogenesis and promotes recovery from ischemic injury in mice.
    Zhu Y; Gao M; Zhou T; Xie M; Mao A; Feng L; Yao X; Wong WT; Ma X
    J Biol Chem; 2019 Jan; 294(1):28-37. PubMed ID: 30413532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria.
    Yu H; Kistler A; Faridi MH; Meyer JO; Tryniszewska B; Mehta D; Yue L; Dryer S; Reiser J
    J Am Soc Nephrol; 2016 Nov; 27(11):3308-3319. PubMed ID: 27020855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels.
    Beckmann H; Richter J; Hill K; Urban N; Lemoine H; Schaefer M
    Cell Calcium; 2017 Sep; 66():10-18. PubMed ID: 28807145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPC5 is required for the NO-dependent increase in dendritic Ca
    Maddox JW; Khorsandi N; Gleason E
    J Neurophysiol; 2018 Jan; 119(1):262-273. PubMed ID: 28978766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Zinc-Dependent Delayed Calcium Influx via TRPC5 in Oxidative Neuronal Death and its Prevention by Novel TRPC Antagonist.
    Park SE; Song JH; Hong C; Kim DE; Sul JW; Kim TY; Seo BR; So I; Kim SY; Bae DJ; Park MH; Lim HM; Baek IJ; Riccio A; Lee JY; Shim WH; Park B; Koh JY; Hwang JJ
    Mol Neurobiol; 2019 Apr; 56(4):2822-2835. PubMed ID: 30062674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
    Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
    Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.